Biocon 52 Week Low Streak: Biocon Ltd. (BIOCON) Trades Near One-Year Low Again

Biocon Ltd. (BIOCON) has now traded within 2% of its 52-week low for its second straight session, extending a two-session pattern that shows a cumulative decline of 2.33% across the streak. At 10:22 AM IST, the stock was trading at Rs 332.55, with the day’s low at Rs 328.65. The latest Univest data confirms this repeated-low pattern, but it does not establish a company-specific cause for the continued move.

The previous close was Rs 333.50, while the stock opened at Rs 335.90 and also touched the same level as the day high. Biocon’s market capitalisation stood at Rs 55,491.09 crore. For readers tracking the Biocon 52 Week Low Streak, the key point is not a one-off intraday move but the persistence of weakness across back-to-back sessions, which keeps the share price near its yearly low zone.

Biocon 52 Week Low Streak: Consecutive Low Analysis

Metric	Value
Current Price	Rs 332.55
Previous Close	Rs 333.5
Today's Move	Rs -0.95 (-0.28%)
Open	Rs 335.9
High	Rs 335.9
Low	Rs 328.65
Market Capitalisation	Rs 55,491.09 crore

Biocon Ltd. (BIOCON) traded at Rs 332.55 versus the previous close of Rs 333.5, a fall of 0.28%. The stock opened at Rs 335.9, reached a high of Rs 335.9, touched a low of Rs 328.65.

Biocon share price today was under mild pressure in early trade, with the stock last traded at Rs 332.55, down Rs 0.95 or 0.28% from the previous close of Rs 333.50. The move kept BIOCON close to the lower end of the day’s range after opening at Rs 335.90 and touching a high of Rs 335.90 before slipping to a low of Rs 328.65. That range places the current price much nearer the day’s lower band than the upper band.

The market capitalisation of Rs 55,491.09 crore keeps Biocon in the conversation among large listed healthcare names, but the short-term price behaviour is clearly weak. In the context of a Biocon 52 Week Low Streak, today’s movement matters less as a standalone session and more as part of the repeated pattern of trading near the one-year trough. For investors following Biocon Share Price, the focus stays on whether the stock can move away from this low zone or continue drifting around it.

What the Repeated 52-Week Lows Show

The Biocon 52 Week Low Streak now spans two consecutive trading sessions, and the cumulative 2.33% decline across that period is the central data point to watch. This tells readers that BIOCON has not merely faced one isolated weak day; it has remained near its 52-week trough across multiple sessions. That repeated pattern is more important than the small day-to-day change because it reflects persistent price weakness around the same low area.

At the same time, the available data confirms the price pattern but does not identify a company-specific trigger. That is a crucial distinction for any Biocon Stock News update. The stock is trading close to its 52-week low again, but the numbers alone do not prove whether the move is being shaped by sentiment, company expectations, sector behaviour or broader market caution. For a reader following Biocon Share Price Update, the factual takeaway is that the downside has continued long enough to merit attention, even without a confirmed catalyst.

Biocon Ltd. (BIOCON) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 55,491.09 crore
P/E Ratio	109.73x
P/B Ratio	1.6x
ROE	1.35%
ROCE	3.26%
EPS	Rs 3.04
Book Value Per Share	Rs 208.53
Dividend Yield	0.15%

Biocon Ltd. (BIOCON) fundamental metrics show P/E 109.73x, P/B 1.6x, ROE 1.35%, ROCE 3.26%. These figures provide context only and are not a buy or sell signal.

Biocon Ltd. has a market capitalisation of Rs 55,491.09 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 109.73x, P/B at 1.6x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 1.35% and ROCE of 3.26%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 3.04, book value per share of Rs 208.53, dividend yield of 0.15%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 26.67x, median ROE of 11.33%, median ROCE of 13.25%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	109.73x
Benchmark Median P/E	26.67x
Benchmark Average P/E	38.42x
Benchmark P/E Range	0x to 616.23x
Company P/B Ratio	1.6x
Benchmark Median P/B	2.7x
Company ROE	1.35%
Benchmark Median ROE	11.33%
Company ROCE	3.26%
Benchmark Median ROCE	13.25%
Company Market Capitalisation	Rs 55,491.09 crore
Benchmark Median Market Cap	Rs 768.75 crore

Biocon Ltd. (BIOCON) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Biocon Ltd. (BIOCON) has a P/E ratio of 109.73x, which is above the benchmark median of 26.67x, a difference of +311.44%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Biocon Ltd. (BIOCON) has a ROE of 1.35%, which is below the benchmark median of 11.33%, a difference of -88.08%. Biocon Ltd. (BIOCON) has a ROCE of 3.26%, which is below the benchmark median of 13.25%, a difference of -75.4%.

Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Abbott India Ltd.	ABBOTINDIA	54,909.79	33.88	10.57	34.67	46.72
Alkem Laboratories Ltd.	ALKEM	59,722.72	27.52	4.15	18.29	21.28
Gland Pharma Ltd.	GLAND	49,952.91	42.75	4.54	10.56	14.96
Glenmark Pharmaceuticals Ltd.	GLENMARK	62,339.2	34.61	5.68	14.1	20.35
Ipca Laboratories Ltd.	IPCALAB	46,049.85	37.13	5.73	15.88	19.41

Biocon Ltd. (BIOCON) has a P/E ratio of 109.73x compared with the displayed peer median of 34.61x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 1.35% compares with a peer median of 15.88% across the companies shown in the table. ROCE stood at 3.26% versus the displayed peer median of 20.35%, providing a capital-efficiency comparison. Biocon Ltd. (BIOCON) has a market capitalisation of Rs 55,491.09 crore. Among the 5 peers shown, 2 have a larger market capitalisation.

Why Investors Are Watching

• The Biocon 52 Week Low Streak has now run for two straight sessions, keeping the stock near its one-year low zone.
• The cumulative decline across the streak is 2.33%, which is more informative than the single-session change alone.
• Biocon’s P/E of 109.73 is well above the industry median, so valuation remains a key part of the Biocon Fundamental Analysis debate.
• The company’s ROE of 1.35% and ROCE of 3.26% are materially below the sector benchmark, which keeps the profitability lens in focus.
• Investors following Biocon Stock News may watch whether the share price can move away from the low zone or remain near the yearly trough.

About the Company

Biocon Ltd. is a healthcare company in the Pharmaceuticals & Drugs industry. Its market capitalisation stands at Rs 55,491.09 crore, placing it among larger listed names in the sector. The company is tracked on both NSE and BSE, and its share price is closely watched by investors looking at healthcare, earnings quality and valuation.

From a fundamentals angle, Biocon’s current numbers show a stock with a high earnings multiple, a lower price-to-book ratio than many peers, and modest return ratios. That combination helps explain why the Biocon 52 Week Low Streak has become a useful lens for Biocon Stock Performance and for anyone following Biocon Company News in the Indian market.

Frequently Asked Questions

What does Biocon 52 Week Low Streak mean?

Ans. It means Biocon Ltd. has traded within 2% of its 52-week low for consecutive sessions. In this case, the streak has lasted two straight sessions, showing repeated trading near the yearly low zone.

How long has Biocon stayed near its 52-week low?

Ans. Biocon has stayed near its 52-week low for a second straight session. The latest Univest data shows a two-session pattern, which is more meaningful than a single-day dip. The stock moved -0.28% during the session.

What is the cumulative move in the Biocon 52 Week Low Streak?

Ans. The cumulative change across the streak is -2.33%. That figure captures the full two-session move and is the main number to track in this Biocon 52 Week Low Streak update.

How is Biocon priced versus sector peers?

Ans. Biocon’s P/E ratio of 109.73 is well above the industry median of 26.67. Its P/B ratio of 1.6 is below the sector median of 2.7, so the valuation picture is mixed rather than simple.

Why is Biocon Share Price being watched closely?

Ans. Biocon Share Price is being watched because the stock remains near its yearly low zone for consecutive sessions. Investors often track whether repeated weakness is sustained or whether the price moves away from that area.

What fundamentals stand out in Biocon Stock Analysis?

Ans. Biocon’s low ROE of 1.35% and ROCE of 3.26% stand out most, especially against sector medians. EPS is Rs 3.04, while book value is Rs 208.53, and dividend yield is 0.15%.

What should investors monitor next in Biocon Stock News?

Ans. Investors may watch whether the share price continues to hover near the one-year low zone, and whether the broader fundamental picture changes. The current Biocon 52 Week Low Streak remains a key signal to track.

Track Biocon Ltd. (BIOCON) Share Price on Univest

Use Biocon Ltd. (BIOCON) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.